effects of stopping semaglutide Ozempic Withdrawal Symptoms weight regain and cardiometabolic effects

GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with type 2 diabetes, according to a new study

The future of obesity treatment will not depend only on discovering new molecules, but also on developing smarter and more patient-friendly ways to deliver them

When branded therapies of semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) commanded high prices and faced prolonged shortages from late 2022 through early 2025, compounding pharmacies emerged as alternative providers offering lower-cost formulations

Semaglutide and Tirzepatide are the hot new weight loss medications on the market

CB0313.1 improved diabetic markers (fasting glucose, glucose tolerance, insulin tolerance, GLP-1 and insulin secretion), and decreased blood lipids and inflammatory tone

7-slot case compact all-in-one for smaller active supplies with syringe storage